Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
study id #: NCT04174157
condition: Spinal Muscular Atrophy (SMA)
status: Recruiting
purpose:Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases.
Until recently, the mainstay of treatment for these patients was supportive medical care. However, advances in medical treatment focusing on gene replacement, gene enhancement, motor neuron protection and muscle enhancement is likely to change the management and prognosis of these patients in the future.
The purpose of this registry is to assess the long term outcomes of patients with SMA in the context of advances in treatment options.
intervention: Prospective observational registry, Zolgensma
results: https://clinicaltrials.gov/ct2/show/results/NCT04174157
last updated: January 13, 2022
-
Early Diagnosis of Spinal Muscular AtrophyUntreated spinal muscular atrophy (SMA) ...
-
Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular AtrophySpinal muscular atrophy (SMA) is an auto...
-
Springfield Second-Grader Attends Class From Home Through Double RoboticsElliette “Ellie” Miller, 8, was diag...
-
Pediatric Spinal Muscular AtrophyWhat is spinal muscular atrophy (SMA)?Sp...
-
Systematic Literature Review to Assess the Cost and Resource Use Associated With Spinal Muscular Atrophy ManagementSpinal muscular atrophy (SMA) is a sever...
-
The Pediatric SMA Clinic – Columbia UniversityThe Pediatric SMA Clinic is committed to...
-
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database AnalysisSpinal muscular atrophy (SMA) is a rare,...